FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4283446048> ?p ?o ?g. }

• W4283446048 endingPage "2160" @default.
• W4283446048 startingPage "2155" @default.
• W4283446048 abstract "Abstract Deucravacitinib, a novel, selective inhibitor of TYK2 is currently under review at the FDA and EMA for treatment of moderate‐to‐severe plaque psoriasis. It is unclear whether recent safety concerns (ie, elevated rates of lung cancer and lymphoma) related to similar medications (ie, other JAK inhibitors) are shared with this novel TYK2 inhibitor. We used a partial loss‐of‐function variant in TYK2 (rs34536443), previously shown to protect against psoriasis and other autoimmune diseases, to evaluate the potential effect of therapeutic TYK2 inhibition on risk of lung cancer and non‐Hodgkin lymphoma. Summary genetic association data on lung cancer risk were obtained from a GWAS meta‐analysis of 29 266 cases and 56 450 controls in the Integrative Analysis of Lung Cancer Risk and Aetiology (INTEGRAL) consortium. Summary genetic association data on non‐Hodgkin lymphoma risk were obtained from a GWAS meta‐analysis of 8489 cases and 374 506 controls in the UK Biobank and InterLymph consortium. In the primary analysis, each copy of the minor allele of rs34536443, representing partial TYK2 inhibition, was associated with an increased risk of lung cancer (OR 1.15, 95% CI 1.09‐1.23, P = 2.29 × 10 −6 ) and non‐Hodgkin lymphoma (OR 1.18, 95% CI 1.05‐1.33, P = 5.25 × 10 −3 ). Our analyses using an established partial loss‐of‐function mutation to mimic TYK2 inhibition provide genetic evidence that therapeutic TYK2 inhibition may increase risk of lung cancer and non‐Hodgkin lymphoma. These findings, consistent with recent reports from postmarketing trials of similar JAK inhibitors, could have important implications for future safety assessment of deucravacitinib and other TYK2 inhibitors in development." @default.
• W4283446048 created "2022-06-26" @default.
• W4283446048 creator A5001258652 @default.
• W4283446048 creator A5008417296 @default.
• W4283446048 creator A5019775307 @default.
• W4283446048 creator A5028989565 @default.
• W4283446048 creator A5048013245 @default.
• W4283446048 creator A5053712654 @default.
• W4283446048 creator A5070118644 @default.
• W4283446048 creator A5071827628 @default.
• W4283446048 creator A5072420085 @default.
• W4283446048 creator A5076124471 @default.
• W4283446048 creator A5089473534 @default.
• W4283446048 date "2022-07-09" @default.
• W4283446048 modified "2023-10-15" @default.
• W4283446048 title "Association of germline <scp>TYK2</scp> variation with lung cancer and <scp>non‐Hodgkin</scp> lymphoma risk" @default.
• W4283446048 cites W1014257459 @default.
• W4283446048 cites W1972696558 @default.
• W4283446048 cites W1979267587 @default.
• W4283446048 cites W1989590412 @default.
• W4283446048 cites W2102889851 @default.
• W4283446048 cites W2119761437 @default.
• W4283446048 cites W2124473941 @default.
• W4283446048 cites W2143556657 @default.
• W4283446048 cites W2547876355 @default.
• W4283446048 cites W2612427157 @default.
• W4283446048 cites W2765253743 @default.
• W4283446048 cites W2806504012 @default.
• W4283446048 cites W2892136519 @default.
• W4283446048 cites W2903533144 @default.
• W4283446048 cites W2906653622 @default.
• W4283446048 cites W2980741989 @default.
• W4283446048 cites W2981477552 @default.
• W4283446048 cites W2999417355 @default.
• W4283446048 cites W3080477490 @default.
• W4283446048 cites W3099912018 @default.
• W4283446048 cites W3164028683 @default.
• W4283446048 cites W4283446048 @default.
• W4283446048 doi "https://doi.org/10.1002/ijc.34180" @default.
• W4283446048 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35747941" @default.
• W4283446048 hasPublicationYear "2022" @default.
• W4283446048 type Work @default.
• W4283446048 citedByCount "2" @default.
• W4283446048 countsByYear W42834460482022 @default.
• W4283446048 countsByYear W42834460482023 @default.
• W4283446048 crossrefType "journal-article" @default.
• W4283446048 hasAuthorship W4283446048A5001258652 @default.
• W4283446048 hasAuthorship W4283446048A5008417296 @default.
• W4283446048 hasAuthorship W4283446048A5019775307 @default.
• W4283446048 hasAuthorship W4283446048A5028989565 @default.
• W4283446048 hasAuthorship W4283446048A5048013245 @default.
• W4283446048 hasAuthorship W4283446048A5053712654 @default.
• W4283446048 hasAuthorship W4283446048A5070118644 @default.
• W4283446048 hasAuthorship W4283446048A5071827628 @default.
• W4283446048 hasAuthorship W4283446048A5072420085 @default.
• W4283446048 hasAuthorship W4283446048A5076124471 @default.
• W4283446048 hasAuthorship W4283446048A5089473534 @default.
• W4283446048 hasBestOaLocation W42834460482 @default.
• W4283446048 hasConcept C104317684 @default.
• W4283446048 hasConcept C106208931 @default.
• W4283446048 hasConcept C121608353 @default.
• W4283446048 hasConcept C126322002 @default.
• W4283446048 hasConcept C135763542 @default.
• W4283446048 hasConcept C143998085 @default.
• W4283446048 hasConcept C153209595 @default.
• W4283446048 hasConcept C2776256026 @default.
• W4283446048 hasConcept C2779338263 @default.
• W4283446048 hasConcept C54355233 @default.
• W4283446048 hasConcept C71924100 @default.
• W4283446048 hasConcept C86803240 @default.
• W4283446048 hasConceptScore W4283446048C104317684 @default.
• W4283446048 hasConceptScore W4283446048C106208931 @default.
• W4283446048 hasConceptScore W4283446048C121608353 @default.
• W4283446048 hasConceptScore W4283446048C126322002 @default.
• W4283446048 hasConceptScore W4283446048C135763542 @default.
• W4283446048 hasConceptScore W4283446048C143998085 @default.
• W4283446048 hasConceptScore W4283446048C153209595 @default.
• W4283446048 hasConceptScore W4283446048C2776256026 @default.
• W4283446048 hasConceptScore W4283446048C2779338263 @default.
• W4283446048 hasConceptScore W4283446048C54355233 @default.
• W4283446048 hasConceptScore W4283446048C71924100 @default.
• W4283446048 hasConceptScore W4283446048C86803240 @default.
• W4283446048 hasFunder F4320310678 @default.
• W4283446048 hasFunder F4320319985 @default.
• W4283446048 hasFunder F4320324195 @default.
• W4283446048 hasIssue "12" @default.
• W4283446048 hasLocation W42834460481 @default.
• W4283446048 hasLocation W42834460482 @default.
• W4283446048 hasLocation W42834460483 @default.
• W4283446048 hasOpenAccess W4283446048 @default.
• W4283446048 hasPrimaryLocation W42834460481 @default.
• W4283446048 hasRelatedWork W1967103478 @default.
• W4283446048 hasRelatedWork W2032912323 @default.
• W4283446048 hasRelatedWork W2104739421 @default.
• W4283446048 hasRelatedWork W2152333375 @default.
• W4283446048 hasRelatedWork W2372561159 @default.
• W4283446048 hasRelatedWork W2375344515 @default.
• W4283446048 hasRelatedWork W2390152934 @default.

• next